Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|November 27, 2007
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trialJasper J Brugts, Eric Boersma, Michel Chonchol, et al.
European Heart Journal|February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of riskJaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
Heart (British Cardiac Society)|December 1, 2006
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA studyAndrew Briggs, Borislava Mihaylova, Mark Sculpher, et al.
European Heart Journal|April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsJasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
The American Journal of Cardiology|January 17, 2012
Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)M Louisa Antoni, Georgette E Hoogslag, Helèn Boden, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 15, 2020
Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST TrialMichael Mahmoudi, Zoe Nicholas, Jacqui Nuttall, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
Pageof 8